Blue Trust Inc
UTHR icon

Blue Trust Inc’s United Therapeutics UTHR Stock Holding History

Blue Trust Inc’s Portfolio UTHR Stock Details UTHR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$274K Sell
506
-216
-30% -$112K ﹤0.01% 666
2026
Q2 		$391K Sell
722
-186
-20% -$105K ﹤0.01% 559
2026
Q1 		$538K Hold
908
– – 0.01% 460
2025
Q4 		$442K Sell
908
-260
-22% -$121K 0.01% 526
2025
Q3 		$490K Sell
1,168
-67
-5% -$22.5K 0.01% 492
2025
Q2 		$355K Buy
1,235
+86
+7% +$25.7K ﹤0.01% 574
2025
Q1 		$354K Hold
1,149
– – ﹤0.01% 516
2024
Q4 		$405K Sell
1,149
-256
-18% -$94.1K 0.01% 432
2024
Q3 		$448K Buy
1,405
+437
+45% +$148K 0.01% 515
2024
Q2 		$222K Buy
968
+285
+42% +$75.4K ﹤0.01% 666
2024
Q1 		$157K Buy
683
+179
+36% +$40.4K ﹤0.01% 586
2023
Q4 		$114K Buy
504
+46
+10% +$10.6K ﹤0.01% 635
2023
Q3 		$101K Buy
458
+279
+156% +$64.3K ﹤0.01% 616
2023
Q2 		$40K Sell
179
-1,196
-87% -$265K ﹤0.01% 775
2023
Q1 		$382K Buy
1,375
+453
+49% +$112K 0.01% 350
2022
Q4 		$193K Buy
922
+597
+184% +$151K ﹤0.01% 464
2022
Q3 		$77K Buy
325
+171
+111% +$38.2K ﹤0.01% 619
2022
Q2 		$28K Buy
+154
New +$31.3K ﹤0.01% 858

Other funds holding UTHR

AssetMark Inc
AssetMark Inc Concord, California $59.5B AUM 15.92% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $118B AUM 40.52% 1-Year Est. Return
Pictet Asset Management
Pictet Asset Management Carouge, Switzerland $106B AUM 32.76% 1-Year Est. Return
Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $83.2B AUM 35.34% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $195B AUM 21.17% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $174B AUM 33.96% 1-Year Est. Return
Seizert Capital Partners
Seizert Capital Partners Birmingham, Michigan $2.3B AUM 16.06% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $103B AUM 40.17% 1-Year Est. Return
Atwood & Palmer
Atwood & Palmer Kansas City, Missouri $1.95B AUM 16% 1-Year Est. Return
KBC Group
KBC Group Brussels, Belgium $47.9B AUM 37.61% 1-Year Est. Return

Blue Trust Inc's UTHR Position: Q3 2026 in Review

Blue Trust Inc reduced its United Therapeutics (UTHR) stake by 30% in Q3 2026, selling an estimated $112K and leaving 506 shares worth $274K. The position accounts for ﹤0.01% of the portfolio, ranked #666.

Blue Trust Inc first reported a position in UTHR in Q2 2022 and has held it in 18 quarters since. The position peaked at $538K in Q1 2026. 292 funds tracked by Wall St. Rank hold UTHR as of Q3 2026.

  • Blue Trust Inc held 506 shares of United Therapeutics worth $274K as of Q3 2026.
  • Blue Trust Inc sold 216 United Therapeutics shares in Q3 2026, an estimated $112K.
  • United Therapeutics made up ﹤0.01% of Blue Trust Inc's portfolio in Q3 2026, its #666 holding.
  • Blue Trust Inc first reported a position in United Therapeutics in Q2 2022 and has held it in 18 quarters since.
  • Blue Trust Inc's United Therapeutics position peaked at $538K in Q1 2026.
  • 292 funds tracked by Wall St. Rank held United Therapeutics as of Q3 2026.

Based on Blue Trust Inc's 13F filing for Q3 2026, filed 15 Oct 2026.